» Articles » PMID: 9590214

Kinetics of Establishing the Memory B Cell Population As Revealed by CD38 Expression

Overview
Journal J Immunol
Date 1998 May 20
PMID 9590214
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

In this report, we detail changes in the expression of CD38 on murine B cells during the course of a T cell-dependent immune response. CD38 is expressed on all naive B cells but is down-regulated on isotype-switched B cells from both the germinal centers (GCs) and the foci of Ab-forming cells which arise during the first weeks of the response. The down-regulation on GC B cells, however, is reversible since Ag-specific IgG1 B cells with high levels of CD38 are apparent by 2 wk postimmunization. These cells have characteristics that resemble recirculating memory B cells, in that they are small and bind low levels of peanut agglutinin. Such characteristics indicate that the restoration of CD38 levels is coincidental with the transition from GC to memory B cell. Using this observation, we plotted the development of the memory population and the demise of the GC reaction as a function of time after immunization. Our results indicate that the GC reaction ceases gradually over many weeks rather than suddenly, which corresponds with the formation of the memory B cell population. Furthermore, by segregating memory B cells and GC B cells, it was possible to assess the in vitro survival characteristics of each compared with naive B cells. These experiments demonstrated that memory B cell survival in vitro was comparable with naive B cell survival but less than the survival seen for bcl-2-transgenic B cells, whereas GC B cell survival, as expected, was very poor. Hence, by resolving murine Ag-specific memory B cells and GC B cells, we have been able to quantify the development of the memory B cell population.

Citing Articles

B Cell Receptor Transgenic Mice as Tools to Study Memory B Cells.

Quast I Methods Mol Biol. 2024; 2826:131-139.

PMID: 39017890 DOI: 10.1007/978-1-0716-3950-4_10.


ISCOMs/MPLA-Adjuvanted SDAD Protein Nanoparticles Induce Improved Mucosal Immune Responses and Cross-Protection in Mice.

Zhu W, Park J, Pho T, Wei L, Dong C, Kim J Small. 2023; 19(34):e2301801.

PMID: 37162451 PMC: 10524461. DOI: 10.1002/smll.202301801.


Recreation of an antigen-driven germinal center in vitro by providing B cells with phagocytic antigen.

Martinez-Riano A, Delgado P, Tercero R, Barrero S, Mendoza P, Oeste C Commun Biol. 2023; 6(1):437.

PMID: 37081131 PMC: 10119099. DOI: 10.1038/s42003-023-04807-0.


Resident Memory B Cells in Barrier Tissues.

Lee C, Oh J Front Immunol. 2022; 13:953088.

PMID: 35924234 PMC: 9341246. DOI: 10.3389/fimmu.2022.953088.


Dichotomy in Neutralizing Antibody Induction to Peptide-Conjugated Vaccine in Squalene Emulsion Contrast With Aluminum Hydroxide Formulation.

Bonduelle O, Chaudesaigues C, Tolazzi M, Suleiman E, de Bernard S, Alves K Front Immunol. 2022; 13:848571.

PMID: 35464449 PMC: 9021396. DOI: 10.3389/fimmu.2022.848571.